PUBLIC CONTRACT · 2022
Vários medicamentos
- Contract value
- €45,179.23
- Signed on
- 3 November 2022
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9553413PUBLISHED DESCRIPTION
61021822 - AQ Urgente Medicamentos
Parties involved
- Awardee
- Boehringer Ingelheim Portugal; BIOPORTUGAL, LDA; EISAI FARMACEUTICA UNIPESSOAL LDA.; Zambon, Prod. Farmacêuticos, Lda.; Teva Pharma - Prod.Farmacêuticos; VIIVHIV HEALTHCARE UNIPESSOAL, LDA; BIOJAM SA; BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL
- Place of performance
- Portugal, Setúbal, Setúbal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Boehringer Ingelheim Portugal · Tax ID 500537410
- Awardee
- BIOPORTUGAL, LDA · Tax ID 502380543
- Awardee
- EISAI FARMACEUTICA UNIPESSOAL LDA. · Tax ID 507847660
- Awardee
- Zambon, Prod. Farmacêuticos, Lda. · Tax ID 502155930
- Awardee
- Teva Pharma - Prod.Farmacêuticos · Tax ID 507045491
- Awardee
- VIIVHIV HEALTHCARE UNIPESSOAL, LDA · Tax ID 509117961
- Awardee
- BIOJAM SA · Tax ID 513642749
- Awardee
- BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL · Tax ID 506415740
Values and timeline
- Contract price
- €45,179.23
- Procedure base price
- €45,179.23
- Total effective price
- Not reported on Portal BASE
- Publication date
- 15 November 2022
- Award date
- 3 November 2022
- Signing date
- 3 November 2022
- Performance period
- 12 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2022/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6144082
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.